# OnCo record quantum-first (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/quantum-first/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "quantum-first", "NCT02668653" ;
  schema:name "QuANTUM-First"@en ;
  schema:description "Roughly doubled median survival in the most aggressive FLT3 subtype by adding a selective FLT3 blocker to chemotherapy, including in patients over 60."@en ;
  schema:url <https://onco.cc/trials/quantum-first/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT02668653>, <https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00464-6/fulltext> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2016-09-01" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/aml-flt3/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/flt3/> ;
  onco:drugs <https://onco.cc/drugs/quizartinib/>, <https://onco.cc/drugs/cytarabine-7-3/> ;
  onco:companies <https://onco.cc/companies/daiichi-sankyo/> ;
  onco:people <https://onco.cc/people/richard-stone/> .